Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Foss

Showing results (41-50 of 258) with videos related to

Pageof 26
Sort By:
Cancer Treatment and Research|January 19, 1999
Novel treatment approaches for cutaneous T-cell lymphomaF M Foss, T M Kuzel
Hematology/Oncology Clinics of North America|October 1, 1995
Chemotherapy for mycosis fungoides and the Sézary syndromeS T Rosen, F M Foss
Clinical Nursing Research|February 1, 1997
A comparison of three oral care products commonly used in practiceA M Foss-Durant, A McAfee
Hematology/Oncology Clinics of North America|January 9, 2004
Interleukin-2 receptor-directed therapies for cutaneous lymphomasFrancine M Foss, Thomas A Waldmann
Cancer Treatment Reviews|February 6, 2007
Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphomaSean J Whittaker, Francine M Foss
Genetics|November 13, 2008
On Spo16 and the coefficient of coincidenceFranklin W Stahl, Henriette M Foss
Hematology/Oncology Clinics of North America|October 1, 1995
Prognosis and staging of cutaneous T-cell lymphomaF M Foss, E A Sausville
Leukemia|June 25, 1998
Arginine butyrate downregulates p210 bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cellsA Urbano, Y Koc, F M Foss
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 1, 1990
Late presentation of congenital dislocation of the hip: an auditS J Gillam, M Foss, M Woolaway
Hematology/Oncology Clinics of North America|October 29, 2008
Cutaneous T-cell lymphomaFrederick Lansigan, Jaehyuk Choi, Francine M Foss
Pageof 26

Showing results (41-50 of 258) with videos related to

Sort By:
Pageof 26
Cancer Treatment and Research|January 19, 1999
Novel treatment approaches for cutaneous T-cell lymphomaF M Foss, T M Kuzel
Hematology/Oncology Clinics of North America|October 1, 1995
Chemotherapy for mycosis fungoides and the Sézary syndromeS T Rosen, F M Foss
Clinical Nursing Research|February 1, 1997
A comparison of three oral care products commonly used in practiceA M Foss-Durant, A McAfee
Hematology/Oncology Clinics of North America|January 9, 2004
Interleukin-2 receptor-directed therapies for cutaneous lymphomasFrancine M Foss, Thomas A Waldmann
Cancer Treatment Reviews|February 6, 2007
Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphomaSean J Whittaker, Francine M Foss
Genetics|November 13, 2008
On Spo16 and the coefficient of coincidenceFranklin W Stahl, Henriette M Foss
Hematology/Oncology Clinics of North America|October 1, 1995
Prognosis and staging of cutaneous T-cell lymphomaF M Foss, E A Sausville
Leukemia|June 25, 1998
Arginine butyrate downregulates p210 bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cellsA Urbano, Y Koc, F M Foss
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 1, 1990
Late presentation of congenital dislocation of the hip: an auditS J Gillam, M Foss, M Woolaway
Hematology/Oncology Clinics of North America|October 29, 2008
Cutaneous T-cell lymphomaFrederick Lansigan, Jaehyuk Choi, Francine M Foss
Pageof 26